KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Revenue (2020 - 2025)

Clover Health Investments' Revenue history spans 6 years, with the latest figure at $487.7 million for Q4 2025.

  • For Q4 2025, Revenue rose 36.64% year-over-year to $487.7 million; the TTM value through Dec 2025 reached $1.9 billion, up 38.46%, while the annual FY2025 figure was $1.9 billion, 40.34% up from the prior year.
  • Revenue reached $487.7 million in Q4 2025 per CLOV's latest filing, down from $496.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $874.4 million in Q1 2022 to a low of $200.3 million in Q1 2021.
  • Average Revenue over 5 years is $402.3 million, with a median of $349.0 million recorded in 2024.
  • Peak YoY movement for Revenue: soared 336.48% in 2022, then crashed 63.74% in 2023.
  • A 5-year view of Revenue shows it stood at $201.0 million in 2021, then skyrocketed by 34.46% to $270.3 million in 2022, then rose by 12.12% to $303.1 million in 2023, then grew by 17.77% to $356.9 million in 2024, then soared by 36.64% to $487.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Revenue are $487.7 million (Q4 2025), $496.6 million (Q3 2025), and $477.6 million (Q2 2025).